Reno-60® is radiopaque contrast agent with a wide range of indications. Reno-60 should be at body temperature when injected and may need to be warmed before use. Following intravascular injection, iodinated contrast materials are transported through the bloodstream to the kidneys and excreted by glomerular filtration.

Renografin®-60 (diatrizoate meglumine and diatrizoate sodium) was used as a radiopaque contrast agent. Bracco Diagnostics, Inc. states that the production of Renografin-60 has been discontinued due to reduced demand.